-
-
Amoxicillin-Clavulanate vs Ciprofloxacin; AD Therapy and Cognitive Function; LDL Lowering in CHD Patients; FDA Actions
-
Palifermin, a recombinant form of human keratinocyte growth factor, reduced the duration and severity of oral mucositis and the incidence of febrile neutropenia and bacteremia among patients given intensive chemotherapy and radiotherapy for hematologic cancers.
-
HHV6 infection occurred primarily during the first 2 years of life. Most infections were symptomatic, but with nonspecific symptoms. Among 81 children with well-defined time of infection, roseola occurred in only 23%. None of these children had febrile seizures.
-
The potential for a clinically detrimental interaction between didanosine and tenofovir disoproxil fumarate (DF) has received considerable attention lately in the medical community. Tenofovir DF is a nucleotide analog of adenosine 5-monophosphate, which was approved by the Food and Drug Administration (FDA) for the treatment of human immunodeficiency virus (HIV) infection in October 2001. Didanosine, 1 of 7 nucleoside reverse transcriptase inhibitors (NRTIs) marketed in the United States, has been implicated as the causative agent significant adverse events such as lactic acidosis/hepatic steatosis, pancreatitis, and peripheral neuropathy.
-
A multicenter study of 4 non-invasive tests for Helicobacter pylori infection in children and adolescents showed the urea breath test to be the preferred diagnostic test, with the greatest sensitivity among all age groups.
-
On February 11, 2005 the New York City Department of Health sent out a Dear Colleague letter reporting the case of a homosexual man who sustained primary infection with a 3-drug-class-resistant HIV-1 accompanied by rapid CD4+ T cell depletion and progression to AIDS.
-
Potentially fatal bacterial infections following platelet transfusions are flying below the infection control radar. The Centers for Disease Control and Prevention (CDC) recently drew attention to the problem by reporting two fatal infections following transfusions and noting that infectious disease physicians have a surprising lack of awareness about the problem.
-
The Centers for Disease Control and Preventions (CDC) Healthcare Infection Control Practices Advisory Committee (HICPAC) recently released a template document for officials seeking to establish infection rate disclosure laws.
-
A leading health care quality group is moving to set national standards for infection rate disclosure laws that essentially would codify recently released guidance by the Centers for Disease Control and Prevention (CDC), Hospital Infection Control has learned.